Nature Inspired Antimicrobial Peptides

This study focuses on Pgopt, an innovative molecule inspired by natural antifungal compounds, with significant potential for treating fungal infections. We aim to investigate how Pgopt works and how it interacts with Candida albicans, a fungal pathogen that can cause opportunistic infections in humans, particularly on the skin. Our ultimate goal is to optimize Pgopt and develop it into an effective therapy for skin infections caused by this fungus. We hypothesize that Pgopt can be further enhanced in terms of stability and antifungal efficacy through targeted modifications. To achieve this, we will analyze how C. albicans responds to Pgopt and use these insights to guide the rational design of improved versions. For instance, we plan to modify Pgopt to make it more resistant to degradation in the body, thereby extending its effectiveness and duration of action. The improved versions of Pgopt will undergo rigorous testing in both laboratory experiments and models that mimic human skin. These tests will evaluate its efficacy, safety, and potential for combination with existing antifungal drugs. To further enhance its performance, we will incorporate Pgopt into specialized nanocarriers. These tiny delivery systems will ensure targeted application of the antifungal molecule to infected areas while also preserving the integrity of the skin barrier. In addition, we will employ advanced imaging techniques and metabolic probes to study how Pgopt interacts with the fungus. This will help us understand how it disrupts the fungal cell structure and metabolism, ultimately inhibiting its growth. We will also examine the genetic response of C. albicans to Pgopt, providing deeper insights into its mode of action. This research is particularly exciting because it combines several innovative approaches: the strategic enhancement of Pgopts stability, the development of a precise delivery system for targeted treatment of skin infections, and a detailed investigation of the funguss immediate response to the therapy. Through this work, we aim not only to develop a novel and effective treatment for fungal skin infections but also to generate valuable insights for the broader scientific community studying C. albicans.

No additional funding sources recorded.